AVGO
35
-2
PSA
58
5
PG
50
2
SLG
62
-4
QCOM
55
-2
ABT
57
-5
DRI
56
2
ETR
68
-3
MLM
57
-3
TEL
74
3
FLR
48
3
C
62
-3
SWK
56
-6
COF
63
-4
DOV
73
4
BMY
61
-3
AON
60
2
KEY
46
-2
AIZ
78
2
SWKS
33
-10
AVGO
35
-2
PSA
58
5
PG
50
2
SLG
62
-4
QCOM
55
-2
ABT
57
-5
DRI
56
2
ETR
68
-3
MLM
57
-3
TEL
74
3
FLR
48
3
C
62
-3
SWK
56
-6
COF
63
-4
DOV
73
4
BMY
61
-3
AON
60
2
KEY
46
-2
AIZ
78
2
SWKS
33
-10
Financhill
Back

Windtree Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
27

WINT
Windtree Therapeutics

Last Price:
0.49
Seasonality Move:
-4.03%
Sell
30

CATX
Perspective Therapeutics

Last Price:
8.92
Seasonality Move:
28.97%
Sell
27
Windtree Therapeutics (WINT) is a Sell

Is Windtree Therapeutics a Buy, Sell or Hold?

  • The current Windtree Therapeutics [WINT] share price is $0.53. The Score for WINT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • WINT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $9.93. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

WINT Stock Price Chart

What is Windtree Therapeutics's stock price today?

  • The Windtree Therapeutics share price today is $0.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $9.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

WINT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 26.02 Sell
Chaikin Money Flow: -363752 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.87) Sell
Bollinger Bands (100): (0.61 - 7.97) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 28.07 Sell
Chaikin Money Flow: -952055 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.27 - 12.77) Sell
Bollinger Bands (100): (11.25 - 14.33) Sell

WINT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.61 Sell
20-day SMA: 0.75 Sell
50-day SMA: 1.69 Sell
200-day SMA: 4.93 Sell
8-day EMA: 0.61 Sell
20-day EMA: 0.84 Sell
50-day EMA: 2.07 Sell
200-day EMA: 11.4 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.45 Sell
20-day SMA: 11.83 Sell
50-day SMA: 12.88 Sell
200-day SMA: 12.8 Sell
8-day EMA: 11.13 Sell
20-day EMA: 11.74 Sell
50-day EMA: 12.46 Sell
200-day EMA: 11.73 Sell

Windtree Therapeutics Earnings Growth & WINT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $92.48 per share, and an increase next year of $0.25 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and a decrease next year of $0.22 per share.

Windtree Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):